Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-07
DOI
10.3389/fimmu.2019.01309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
- (2018) Salvatore Sciacchitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
- (2017) Elisabeth Schrumpf et al. JOURNAL OF HEPATOLOGY
- Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis
- (2017) Bei-Bei Zhang et al. PLoS One
- Galectin-3 regulates inflammasome activation in cholestatic liver injury
- (2016) Jijing Tian et al. FASEB JOURNAL
- Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
- (2016) John Stegmayr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages
- (2016) Bojana Simovic Markovic et al. Journal of Crohns & Colitis
- Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis
- (2016) Bojana Simovic Markovic et al. Stem Cells International
- Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens
- (2016) Aleksandar Arsenijevic et al. Scientific Reports
- Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference
- (2015) Swey-Shen Chen et al. CELLULAR IMMUNOLOGY
- Galectin-3 in autoimmunity and autoimmune diseases
- (2015) Felipe L de Oliveira et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain
- (2015) Michelle C Miller et al. GLYCOBIOLOGY
- CXCR5+CD4+T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis
- (2015) Lifeng Wang et al. HEPATOLOGY
- The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis
- (2015) TianYan Shi et al. MEDICINE
- Unknown
- (2015) Ilija Jeftic et al. MOLECULAR MEDICINE
- Inflammasome activation and function in liver disease
- (2015) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes
- (2014) N. Demotte et al. CLINICAL CANCER RESEARCH
- Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury
- (2014) Vladislav Volarevic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis
- (2014) Jun Zhang et al. HEPATOLOGY
- Galectin-3 Is a Negative Regulator of Lipopolysaccharide-Mediated Inflammation
- (2014) Y. Li et al. JOURNAL OF IMMUNOLOGY
- Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis
- (2013) Cheng Qian et al. CYTOKINE
- IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy
- (2013) Chen-Yen Yang et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Galectin-3 Interactions with Glycosphingolipids
- (2013) Patrick M. Collins et al. JOURNAL OF MOLECULAR BIOLOGY
- Identification of Potential Cytokine Pathways for Therapeutic Intervention in Murine Primary Biliary Cirrhosis
- (2013) Kazuhito Kawata et al. PLoS One
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- The roles of Galectin-3 in autoimmunity and tumor progression
- (2012) Gordana Radosavljevic et al. IMMUNOLOGIC RESEARCH
- Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis
- (2011) Shinji Shimoda et al. HEPATOLOGY
- Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice
- (2011) Vladislav Volarevic et al. HEPATOLOGY
- Apotopes and the biliary specificity of primary biliary cirrhosis
- (2009) Ana Lleo et al. HEPATOLOGY
- Liver Autoimmunity Triggered by Microbial Activation of Natural Killer T Cells
- (2008) Jochen Mattner et al. Cell Host & Microbe
- Hepatic IL-17 responses in human and murine primary biliary cirrhosis
- (2008) Ruth Y.Z. Lan et al. JOURNAL OF AUTOIMMUNITY
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started